Contract Research Organization (CRO) Business Valuation
Value a clinical research organization or CRO using backlog multiples, EBITDA, and revenue per FTE benchmarks. Reports.
29 valuation methods · 43 industries · Results in under 10 minutes
Who this is for
CRO founders evaluating PE investment or strategic acquisition, pharma corporate development teams assessing CRO partnerships, and life sciences investors benchmarking portfolio CRO assets.
Valuation methods we use
CROs are valued at 8–15× EBITDA, with premiums for oncology specialization, large backlog coverage, and preferred sponsor relationships. Revenue multiples (1–3×) and backlog multiples provide secondary validation. This tool is informational only. Output is driven by your inputs and does not constitute a formal appraisal or certified valuation.
What drives value in CRO Services
- Backlog size and book-to-bill ratio as a revenue visibility indicator
- Therapeutic area specialization (oncology, rare disease) commanding premium rates
- Regulatory track record and FDA-facing submission experience
- Site network breadth and patient recruitment capability
- Repeat sponsor relationships and preferred vendor agreements
- Revenue per scientific FTE as a productivity benchmark
Value your business in under 10 minutes
- 1.Upload your financial statements, or type the figures in.
- 2.Confirm the add-backs and the industry details the model asks for.
- 3.Get a valuation range, the methods behind it and a PDF memorandum.
Typical metrics and inputs
Backlog
Total contracted future revenue not yet recognized; typically 12–24 months of forward revenue for well-positioned CROs.
Book-to-bill ratio
New awards divided by revenue recognized in the period; >1.0× signals growth; <0.9× signals contraction.
Revenue per FTE
Annual revenue divided by total headcount; benchmark is $120K–$250K for mid-size CROs.
EBITDA margin
Typically 12–22% for specialized CROs after R&D labor and overhead.
Repeat sponsor revenue %
Revenue from sponsors who awarded work in the prior year; high repeat rates indicate quality delivery.
Example scenarios
Oncology-focused Phase 1-2 CRO
A specialized oncology CRO with $20 M revenue, $30 M backlog, and 18% EBITDA might be valued at 10–13× EBITDA by a strategic pharma acquirer.
General-purpose mid-size CRO
A broad-spectrum CRO with $40 M revenue, diversified therapeutic areas, and 15% EBITDA margins might trade at 8–10× EBITDA.
Further reading
How to Value a Dental Practice: Collections, EBITDA, and What DSOs Actually Pay
Dental practice valuation explained: the percentage-of-collections rule, when EBITDA multiples take over, what drives DSO offers, and a worked example for a $900K practice.
Is a Business Worth 3 Times Profit? When It Is 2x, When It Is 5x, and Which Profit Counts
Is a business worth 3 times profit? Often, if the profit is SDE. When 2x or 5x applies instead, which profit counts, and what diligence does to the price.
How Much Is a Business Worth With $500,000 in Sales? The Revenue Ladder From $100K to $3 Million
Revenue does not set a price, earnings do. See what businesses at $100K, $200K, $300K, $500K, $1M, $2M and $3M in sales are worth at 10%, 20% and 30% margins.
Frequently asked questions
What multiple does a CRO sell for?
Specialized CROs trade at 10–15× EBITDA; general-purpose mid-size CROs at 7–10×. Strategic acquirers may pay higher for capability or geographic access.
How important is backlog in CRO valuation?
Critical - backlog provides revenue visibility and de-risks projections. Buyers typically want 12+ months of backlog coverage before paying a full multiple.
Does FDA experience add to CRO value?
Yes - CROs with a track record of successful NDA/BLA submissions command premium rates and multiples due to regulatory risk mitigation for sponsors.
How does therapeutic area specialization affect CRO valuation?
Oncology and rare disease specialists earn higher per-patient and per-study revenues, command stronger repeat business, and attract strategic acquirer premiums.
Is this a certified appraisal?
No. This tool provides informational estimates. For formal CRO M&A, engage a life sciences M&A advisor.
As featured in
Run your CRO Services valuation
Get a valuation range with the methods behind it and a PDF memorandum in under 10 minutes.
Related industries
Biotech & Pharma
Value a biotech or pharmaceutical company using rNPV, pipeline analysis, and pharma comparable transactions.
Healthcare Services
Value a healthcare services company on normalized EBITDA, with the multiple chosen from the payer mix: commercial insurers pay more than government plans.
Professional Services
Value a consulting, accounting or agency business on its earnings, with seller's discretionary earnings in the blend for a smaller owner-run firm.
Staffing
Value a staffing or recruiting agency on its earnings, with margin per hour, client concentration and recruiter productivity read the way buyers do.